Form 4: Atlassian Co-Founder Sells $1.1M in Shares
Insider Transaction Report
Atlassian Co-Founder and CEO Michael Cannon-Brookes reported the sale of 7,665 shares of Class A Common Stock totaling approximately $1.1 million under a pre-arranged 10b5-1 trading plan.
Summary
- Michael Cannon-Brookes, Atlassian's Co-Founder, CEO, Director, and 10% Owner, reported the sale of Class A Common Stock.
- A total of 7,665 shares were sold across four separate transactions on November 18, 2025.
- The sales were executed at weighted-average prices ranging from $145.9971 to $148.8567 per share.
- The total value of shares sold is approximately $1,129,000.
- These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- Following these transactions, Cannon-Brookes indirectly beneficially owns 222,285 shares of Class A Common Stock through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While it's an insider sale, which can sometimes be viewed negatively, the fact that it's executed under a pre-arranged 10b5-1 plan adopted well in advance (February 20, 2025) indicates a planned diversification or liquidity event rather than a reaction to adverse company news. This mitigates any negative interpretation.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned sale rather than a reaction to recent events or material non-public information.
Negatives
- An insider sale, even if pre-planned, can sometimes be perceived as a lack of confidence by some investors, though this is largely mitigated by the 10b5-1 plan.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Management Comments
- This filing does not contain direct quotes or paraphrased statements from company management, as it is a transactional report.
Industry Context
This insider transaction is a routine disclosure for public company executives and does not inherently reflect broader industry trends. Sales under 10b5-1 plans are common for executives to manage personal finances and diversify holdings without concerns of trading on material non-public information.
Comparison to Industry Standards
- This filing is a standard Form 4 disclosure for an insider stock transaction.
- The use of a Rule 10b5-1 trading plan aligns with best practices for corporate governance, providing a defense against insider trading allegations by pre-scheduling trades.
Related Party Transactions
- Shares are held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust, indicating indirect beneficial ownership through a related entity. The reported transactions are sales by the reporting person, not directly by the trust.
Stakeholder Impact
- The impact on shareholders is minimal. Routine insider sales under 10b5-1 plans are common and generally do not signal significant changes in company prospects.
- Employees, customers, suppliers, and creditors are unlikely to be directly impacted by this specific transaction.
Next Steps
- This filing does not mention any specific future actions, events, or milestones for the company or the reporting person beyond the reported transactions.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 11/18/2025 | Date of reported stock transactions (sales of Class A Common Stock). |
| 11/19/2025 | Date the Form 4 filing was signed. |
Recommendation
holdThis Form 4 reports a routine insider sale by Michael Cannon-Brookes under a pre-established 10b5-1 trading plan. Such planned sales are common for executives for personal financial management and diversification and do not typically indicate a change in the company's fundamental outlook or warrant a shift in investment recommendation. Investors should continue to evaluate Atlassian based on its operational performance and strategic initiatives.
Keywords
Atlassian, TEAM, Michael Cannon-Brookes, insider trading, Form 4, stock sale, 10b5-1 plan, executive compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.